Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat.

The purpose of this research was to identify the major factors controlling the distribution of beta-blockers (acebutolol, betaxolol, bisoprolol, metoprolol, oxprenolol, pindolol, propranolol and timolol) in rats, across tissues, compounds and enantiomers. Tissue distribution was assessed at steady state by infusing cassette doses of beta-blockers into the jugular vein via an indwelling catheter at a constant rate. Blood was sampled via an indwelling catheter in the carotid artery, and 12 tissues excised at the end of dose infusion (4 or 8 h). Drug concentrations were quantified using a novel chiral LC-MS method and the tissue-to-plasma (Kp) and tissue-to-plasma water (Kpu) values were calculated for each tissue. Differences between Kp were observed between many enantiomeric pairs, and largely explained by enantiomeric differences in plasma protein binding. Across compounds, Kpu values were generally highest in lung and lowest in adipose, and were higher for the more lipophilic drugs betaxolol and propranolol. For any tissue, Kpu differences between the individual beta-blockers correlated well with the corresponding affinity for blood cells. For all compounds, regional tissue distribution correlated well with tissue acidic phospholipid concentrations, with phosphatidylserine appearing to have the strongest influence. This information may be used as the basis for predicting the tissue distribution of basic drugs.

[1]  F. Bressolle,et al.  Validation of liquid chromatographic and gas chromatographic methods. Applications to pharmacokinetics. , 1996, Journal of chromatography. B, Biomedical applications.

[2]  Ryosei Kawai,et al.  Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125 , 1994, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  M. Burt,et al.  Chronic arterial and venous access in the unrestrained rat. , 1980, The American journal of physiology.

[4]  M. Piquette-Miller,et al.  PHARMACOKINETICS AND MULTIPLE PEAKING OF ACEBUTOLOL ENANTIOMERS IN RATS , 1997, Biopharmaceutics & drug disposition.

[5]  Toshio Kimura,et al.  Stereoselective binding of β‐blockers to purified rat α1‐acid glycoprotein , 1993 .

[6]  G. Schuhmann,et al.  Prediction of drug distribution in vivo on the basis of in vitro binding data. , 1987, Biopharmaceutics & drug disposition.

[7]  J. Weinberg,et al.  Identification of the aminoglycoside binding site in rat renal brush border membranes. , 1982, The Journal of pharmacology and experimental therapeutics.

[8]  D. Abramson,et al.  THE LIPID COMPOSITION OF NORMAL RAT THYMUS. , 1965, Biochimica et biophysica acta.

[9]  J. Hawthorne,et al.  Phospholipids : chemistry, metabolism and function , 1964 .

[10]  K. Hostetler,et al.  An improved two dimensional thin-layer chromatography system for the separation of phosphatidylglycerol and its derivatives. , 1976, Journal of lipid research.

[11]  J Ermer,et al.  Validation in pharmaceutical analysis. Part I: an integrated approach. , 2001, Journal of pharmaceutical and biomedical analysis.

[12]  C. Bazil,et al.  Equilibration of Halothane with Brain Tissue In Vitro: Comparison to Brain Concentrations During Anesthesia , 1987, Journal of neurochemistry.

[13]  B A Telfer,et al.  Tissue water content in rats measured by desiccation. , 1997, Journal of pharmacological and toxicological methods.

[14]  Malcolm Rowland,et al.  Clinical pharmacokinetics : concepts and applications , 1989 .

[15]  H. Ogata,et al.  Plasma protein binding of propranolol enantiomers as a major determinant of their stereoselective tissue distribution in rats. , 1990, The Journal of pharmacology and experimental therapeutics.

[16]  R. Andersson,et al.  Antioxidant and calcium channel blockers counteract endothelial barrier injury induced by acute pancreatitis in rats. , 1995, Scandinavian journal of gastroenterology.

[17]  R. Pownall,et al.  The absorption of β‐adrenoceptor antagonists in rat in‐situ small intestine; the effect of lipophilicity , 1985, The Journal of pharmacy and pharmacology.

[18]  F. Theil,et al.  Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs. , 2001, Journal of pharmaceutical sciences.

[19]  F. Theil,et al.  A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. , 2000, Journal of pharmaceutical sciences.

[20]  R. Groscolas,et al.  Incorporation of n-3 fatty acids into phospholipids of rat liver and white and brown adipose tissues: A time-course study during fish-oil feeding , 1995 .

[21]  B. Fichtl,et al.  Tissue Binding versus Plasma Binding of Drugs: General Principles and Pharmacokinetic Consequences , 1991 .

[22]  D. Cutler,et al.  The potential role of lysosomes in tissue distribution of weak bases , 1988, Biopharmaceutics & drug disposition.

[23]  Y. Sugiyama,et al.  Experimental evidence of characteristic tissue distribution of adriamycin. Tissue DNA concentration as a determinant , 1982, The Journal of pharmacy and pharmacology.

[24]  A. Ryrfeldt,et al.  Transport and binding of lidocaine by lung slices and perfused lung of rats. , 2009, Acta pharmacologica et toxicologica.

[25]  Y. Sai,et al.  Active Secretion of Drugs from the Small Intestinal Epithelium in Rats by P‐Glycoprotein Functioning as an Absorption Barrier , 1996, The Journal of pharmacy and pharmacology.

[26]  A. Wilson,et al.  Studies on the persistence of basic amines in the rabbit lung. , 1979, Drug metabolism and disposition: the biological fate of chemicals.

[27]  R. Jain,et al.  Extracellular water measurements: organ tracer kinetics of bromide and sucrose in rats and man. , 1978, The American journal of physiology.

[28]  T. Murakami,et al.  Phosphatidylserine as a Determinant for the Tissue Distribution of Weakly Basic Drugs in Rats , 1990, Pharmaceutical Research.

[29]  O. Koldovský,et al.  FATTY ACID COMPOSITION IN DEVELOPING RATS. FATTY ACID COMPOSITION OF TRIGLYCERIDES AND PHOSPHOLIPIDS IN SOME ORGANS OF THE RAT DURING POSTNATAL DEVELOPMENT. , 1964, Biochimica et biophysica acta.

[30]  L. Hovsepyan,et al.  Quantitative analysis of phospholipids and gangliosides in bone marrow progenitors of lymphocytes, thymocytes and mature lymphocytes in tumor-bearing animals. , 2001, International immunology.

[31]  N. Nicolaides.  Skin lipids. II. Lipid class composition of samples from various species and anatomical sites , 1965, Journal of the American Oil Chemists' Society.

[32]  G. Rouser,et al.  Variations among vertebrates of lung phospholipid class composition , 1969, Lipids.

[33]  L. Masotti,et al.  Postnatal maturation of rat intestinal membrane: lipid composition and fluidity. , 1991, Comparative biochemistry and physiology. A, Comparative physiology.

[34]  A. Somlyo,et al.  VASCULAR SMOOTH MUSCLE , 1968 .

[35]  K. Hanada,et al.  Enantioselective Tissue Distribution of the Basic Drugs Disopyramide, Flecainide and Verapamil in Rats: Role of Plasma Protein and Tissue Phosphatidylserine Binding , 1998, Pharmaceutical Research.

[36]  O. Wassermann,et al.  NMR-studies on the molecular basis of drug-induced phospholipidosis--II. Interaction between several amphiphilic drugs and phospholipids. , 1976, Biochemical pharmacology.

[37]  G. Rouser,et al.  Species variations in phospholipid class distribution of organs: I. Kidney, liver and spleen , 1969, Lipids.

[38]  T. Murakami,et al.  Role of acidic phospholipids in tissue distribution of quinidine in rats. , 1987, Journal of pharmacobio-dynamics.

[39]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[40]  J. Hawthorne,et al.  Form and function of phospholipids. , 1973 .

[41]  T. Walle,et al.  Stereoselective binding of the (-)-enantiomer of propranolol to plasma and extravascular binding sites in the dog. , 1983, Drug Metabolism And Disposition.

[42]  G. Rouser,et al.  Species variations in phospholipid class distribution of organs: II. Heart and skeletal muscle , 1969, Lipids.

[43]  M. Moor,et al.  Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. I. Barbiturates. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[44]  R. Shanks,et al.  Clinical Pharmacokinetics of β-Adrenoceptor Antagonists , 1987 .

[45]  P. Wertz,et al.  A survey of polar and non-polar lipids of mouse organs. , 1985, Comparative biochemistry and physiology. B, Comparative biochemistry.

[46]  MARCEL H. BICKEL,et al.  Drug distribution as a function of binding competition. Experiments with the distribution dialysis technique , 1980, The Journal of pharmacy and pharmacology.

[47]  C. Schmitges,et al.  High &bgr;1‐Selectivity and Favourable Pharmacokinetics as the Outstanding Properties of Bisoprolol , 1985, Journal of cardiovascular pharmacology.

[48]  M. Wehling,et al.  The binding of drugs to different polar lipids in vitro. , 1979, Biochemical pharmacology.

[49]  Patrick Poulin,et al.  Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. , 2002, Journal of pharmaceutical sciences.

[50]  P. Bullough,et al.  The Effects of Trifluoperazine on Calcifying Tissues in the Immature Rat , 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[51]  P. Hinderling,et al.  Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man , 1984, Journal of Pharmacokinetics and Biopharmaceutics.

[52]  M. Rowland,et al.  Prediction of in Vivo Tissue Distribution from in Vitro Data. 2. Correlation Between in Vitro and in Vivo Tissue Distribution of a Homologous Series of Nine 5-n-Alkyl-5-Ethyl Barbituric Acids , 2003, Pharmaceutical Research.

[53]  Differential tissue distribution of the enantiomers of racemic pindolol in the rat , 1999, European Neuropsychopharmacology.

[54]  R. Schoenwald,et al.  Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors , 1983 .